Professor | Hanxiang Nie | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Hanxiang Nie
Contact Information	nhxbj@sohu.com
Language ability	English, Chinese
Province	Hubei

Upload Avatar (500 x 500)

Name

Hanxiang Nie

Contact Information

nhxbj@sohu.com

Language ability

English, Chinese

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	1989-1994: Bachelor of Clinical Medicine, Hubei Medical University 1998-2001: Master of Internal Medicine, Wuhan University 2004-2007: PhD in Internal Medicine, Wuhan University Led 5 National Natural Science Foundation projects Published over 40 SCI papers
Work Experience	1994-1998: Resident Physician, Zhongshan Hospital, Hubei Province 2001: Resident Physician, Renmin Hospital of Wuhan University 2001-Present: Attending Physician/Associate Chief Physician/Associate Professor/Professor/Second-level Chief Physician, Renmin Hospital of Wuhan University
Awards	2014: Second Prize, Hubei Province Science and Technology Progress for 'Mechanism and Clinical Application of Asthma' 2012: Third Prize, Wuhan Science and Technology Progress for 'Study on the Significance of Induced Sputum Inflammatory Markers in the Diagnosis and Treatment Evaluation of Bronchial Asthma' 2005: Third Prize, Hubei Province Science and Technology Progress for 'Clinical and Anti-inflammatory Effects of Low-dose Theophylline in the Treatment of Bronchial Asthma' 2003: Hubei Province Outstanding Master's Thesis for 'Effects of Low-dose Theophylline on Induced Sputum CD4+ T Cells, Interleukin-5, and Interferon-γ Levels in Asthma Patients'

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

1989-1994: Bachelor of Clinical Medicine, Hubei Medical University
1998-2001: Master of Internal Medicine, Wuhan University
2004-2007: PhD in Internal Medicine, Wuhan University
Led 5 National Natural Science Foundation projects
Published over 40 SCI papers

Work Experience

1994-1998: Resident Physician, Zhongshan Hospital, Hubei Province
2001: Resident Physician, Renmin Hospital of Wuhan University
2001-Present: Attending Physician/Associate Chief Physician/Associate Professor/Professor/Second-level Chief Physician, Renmin Hospital of Wuhan University

Awards

2014: Second Prize, Hubei Province Science and Technology Progress for 'Mechanism and Clinical Application of Asthma'
2012: Third Prize, Wuhan Science and Technology Progress for 'Study on the Significance of Induced Sputum Inflammatory Markers in the Diagnosis and Treatment Evaluation of Bronchial Asthma'
2005: Third Prize, Hubei Province Science and Technology Progress for 'Clinical and Anti-inflammatory Effects of Low-dose Theophylline in the Treatment of Bronchial Asthma'
2003: Hubei Province Outstanding Master's Thesis for 'Effects of Low-dose Theophylline on Induced Sputum CD4+ T Cells, Interleukin-5, and Interferon-γ Levels in Asthma Patients'

Areas of Focus	Bronchial asthma: its pathogenesis and treatment
Publications	Cross-talk of four types of RNA modification writers defines the immune microenvironment in severe asthma, Lin Q, Ni H, Zheng Z, Zhong J, Nie H, 2022 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study, Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, Ni F, Fang S, Lu Y, Ding X, Liu H, Ewing RM, Jones MG, Hu Y, Nie H, Wang Y, 2021 Anti-F4/80 treatment attenuates Th2 cell responses: Implications for the role of lung interstitial macrophages in the asthmatic mice, Deng N, Guo X, Chen Q, Liu L, Chen S, Wang A, Li R, Huang Y, Ding X, Yu H, Hu S, Zhao Y, Chen X, Nie H, 2021 Blockade of CD40L inhibits immunogenic maturation of lung dendritic cells: Implications for the role of lung iNKT cells in mouse models of asthma, Deng N, Chen Q, Guo X, Liu L, Chen S, Wang A, Li R, Huang Y, Ding X, Yu H, Hu S, Zhao Y, Chen X, Nie H, 2020 α-Galactosylceramide treatment before allergen sensitization promotes iNKT cell-mediated induction of Treg cells, preventing Th2 cell responses in murine asthma, Chen Q, Guo X, Deng N, Liu L, Chen S, Wang A, Li R, Huang Y, Ding X, Yu H, Hu S, Nie H, 2019 α-Galactosylceramide generates lung regulatory T cells through the activated natural killer T cells in mice, Chen Q, Guo X, Deng N, Liu L, Chen S, Wang A, Li R, Huang Y, Ding X, Yu H, Hu S, Nie H, 2019 The role of plasma N-terminal brain natriuretic pro-peptide in diagnosing elderly patients with acute exacerbation of COPD concurrent with left heart failure, Guo X, Nie H, Chen Q, Chen S, Deng N, Li R, Ding X, Hu S, Wang A, 2018 Invariant natural killer T cells promote immunogenic maturation of lung dendritic cells in an ovalbumin-induced mouse model of allergic asthma, He Q, Liu L, Yang Q, Wang A, Chen S, Li R, Huang Y, Zhang G, Ding X, Yu H, Hu S, Nie H, 2017 Efficacy of theophylline plus salmeterol/fluticasone propionate combination therapy in patients with asthma, Nie H, Zhang G, Liu M, Ding X, Huang Y, Hu S, 2013 Sulfatide-activated type II NKT cells prevent allergic airway inflammation by inhibiting type I NKT cell function in a mouse model of asthma, Zhang G, Nie H, Yang J, Ding X, Huang Y, Yu H, Li R, Yuan Z, Hu S, 2011

Areas of Focus

Bronchial asthma: its pathogenesis and treatment

Publications

Cross-talk of four types of RNA modification writers defines the immune microenvironment in severe asthma, Lin Q, Ni H, Zheng Z, Zhong J, Nie H, 2022
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study, Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, Ni F, Fang S, Lu Y, Ding X, Liu H, Ewing RM, Jones MG, Hu Y, Nie H, Wang Y, 2021
Anti-F4/80 treatment attenuates Th2 cell responses: Implications for the role of lung interstitial macrophages in the asthmatic mice, Deng N, Guo X, Chen Q, Liu L, Chen S, Wang A, Li R, Huang Y, Ding X, Yu H, Hu S, Zhao Y, Chen X, Nie H, 2021
Blockade of CD40L inhibits immunogenic maturation of lung dendritic cells: Implications for the role of lung iNKT cells in mouse models of asthma, Deng N, Chen Q, Guo X, Liu L, Chen S, Wang A, Li R, Huang Y, Ding X, Yu H, Hu S, Zhao Y, Chen X, Nie H, 2020
α-Galactosylceramide treatment before allergen sensitization promotes iNKT cell-mediated induction of Treg cells, preventing Th2 cell responses in murine asthma, Chen Q, Guo X, Deng N, Liu L, Chen S, Wang A, Li R, Huang Y, Ding X, Yu H, Hu S, Nie H, 2019
α-Galactosylceramide generates lung regulatory T cells through the activated natural killer T cells in mice, Chen Q, Guo X, Deng N, Liu L, Chen S, Wang A, Li R, Huang Y, Ding X, Yu H, Hu S, Nie H, 2019
The role of plasma N-terminal brain natriuretic pro-peptide in diagnosing elderly patients with acute exacerbation of COPD concurrent with left heart failure, Guo X, Nie H, Chen Q, Chen S, Deng N, Li R, Ding X, Hu S, Wang A, 2018
Invariant natural killer T cells promote immunogenic maturation of lung dendritic cells in an ovalbumin-induced mouse model of allergic asthma, He Q, Liu L, Yang Q, Wang A, Chen S, Li R, Huang Y, Zhang G, Ding X, Yu H, Hu S, Nie H, 2017
Efficacy of theophylline plus salmeterol/fluticasone propionate combination therapy in patients with asthma, Nie H, Zhang G, Liu M, Ding X, Huang Y, Hu S, 2013
Sulfatide-activated type II NKT cells prevent allergic airway inflammation by inhibiting type I NKT cell function in a mouse model of asthma, Zhang G, Nie H, Yang J, Ding X, Huang Y, Yu H, Li R, Yuan Z, Hu S, 2011

Asthma Pathogenesis Treatment Respiratory Diseases Inflammation Immune Response Clinical Research Therapeutics Lung Function Disease Management

Zhang Guqin - Wuhan University

Li Zhang - Wuhan University

Bing Liu - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us